Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Recursion Pharmaceuticals shows high cash burn, limited efficacy data, and unproven platform validation. Check out why RXRX ...

Enterprises adopting AI cannot afford to be slowed by database lock-in. As the vector ecosystem evolves, the winners will be ...

Vanguard FTSE Developed Markets ETF VEA has a market-cap-weighted portfolio that holds nearly all stocks in the developed international market. Its low fee and expansive portfolio make it one of the ...

This month in security with Tony Anscombe – October 2025 edition From the end of Windows 10 support to scams on TikTok and state-aligned hackers wielding AI, October's headlines offer a glimpse of ...

Unlike non-human primates, songbirds learn to vocalize very much like human infants learn to speak. In both cases, young individuals form auditory memories of the vocalizations of adults during a ...

The single market ensures the free movement of goods, services, capital and people. It facilitates everyday life, stimulates growth and boosts innovation. Established in 1993, the EU single market is ...